Equibles does not estimate personal net worth.
The proxy statement of Pennant Group, Inc. reports total compensation of $365,312 for Derek Bunker in fiscal 2022, including a base salary of $233,000. Disclosed compensation is on record for 4 fiscal years. Derek Bunker has spoken on 2 earnings calls across 1 company, most recently for Pennant Group, Inc. on May 9, 2022. The companies whose calls Derek Bunker spoke on are classified in the Healthcare sector.
“Here with me today, I have Daniel Walker, our CEO; Brent Guerisoli, our President; Jennifer Freeman, our CFO; and John Gochnour, our COO. Before we begin, I have a few housekeeping matters.”
“Here with me today I have Danny Walker, our CEO; Jen Freeman, our CFO and John Gochnour, our COO. Before we begin, I have a few housekeeping matters. We filed our earnings press release and 10-Q yesterday.”
Proxy statement
Start not stated–2019-10-01
PNTG
Medical Care Facilities · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Pennant Group, Inc. (PNTG) | Chief Investment Officer | $233,000 | $365,312 |
| 2021 | Pennant Group, Inc. (PNTG) | Chief Investment Officer | $221,883 | $441,788 |
| 2020 | Pennant Group, Inc. (PNTG) | Chief Investment Officer | $213,451 | $572,044 |
| 2019 | Pennant Group, Inc. (PNTG) | Chief Investment Officer, Executive Vice President and Secretary Mr. Walker’s 2019 stock award consists of 1,192,842 restricted stock units in connection with the Spin-Off that will fully vest on the third anniversary of the grant. The restricted stock units were granted on October 1, 2019 with a fair value at the grant date of $15.09 per share. Mr. Walker was provided this one-time grant by the Board of Directors in recognition of his role as a founder of Cornerstone Healthcare, Inc., our home health and hospice subsidiary, which prior to the Spin-Off was a subsidiary of Ensign. 2019 total reflects compensation for the period after the Spin-Off earned from October 1, 2019, through December 31, 2019. Prior to October 1, 2019, the Company was a wholly owned subsidiary of Ensign, our former parent company. Prior to the Spin-Off, the cash compensation of our NEOs was determined by Ensign’s executive management or its board of directors and the equity compensation of our NEOs was determined by Ensign’s compensation committee at the recommendation of Ensign’s executive management. Accordingly, the compensation paid to our NEOs for fiscal year 2019 is not necessarily indicative of how we will compensate our named executive officers in future years. Mr. Guerisoli was appointed President of the Company effective January 1, 2021. Prior to that date, Mr. Guerisoli served as the President of the Company’s home health and hospice segment. | $52,500 | $380,769 |
